InvestorsHub Logo

Juice555

09/22/17 1:12 PM

#5608 RE: Sky10 #5607

Yes. Saw that drop from 20 to 3 and read up about it and the first thing that came to mind is great. One less competitor

I just hoops OPK will get through the data and find the "problem" with or having to retrial. And we also have the kids trial going on

Technology works ( elonova by Merck is being used in Europe with the same technology, it's the only application outside OPK basket for CTP)